Series B - Enterprise Therapeutics - 2024-01-29 - Crunchbase

life-sciences-europe.com — Enterprise Therapeutics–SEVERAL: investment, 202401 financing round Series B follow-on £26m led by Panakès Partners News • Jan 30, 2024 Business Wire …

CouponFollow Extension

£26
OFF

Series B - Enterprise Therapeutics - 2024-01-29 - Crunchbase

6 days from now

life-sciences-europe.com — Enterprise Therapeutics–SEVERAL: investment, 202401 financing round Series B follow-on £26m led by Panakès Partners News • Jan 30, 2024 Business Wire …

crunchbase.com

$33
OFF

Enterprise Therapeutics Closes £26 Million ($33.1 Million) Series B ...

6 days from now

Brighton, UK, 30 January 2024: Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives …

enterprisetherapeutics.com

$33
OFF

Enterprise Therapeutics Closes £26 Million ($33.1 Million) Series B ...

6 days from now

(accessed November 18, 2024). Harvard. Enterprise Therapeutics Ltd. 2024. Enterprise Therapeutics closes £26 million ($33.1 million) Series B follow-on financing. News-Medical, …

news-medical.net

$33
OFF

Enterprise Therapeutics Closes £26 Million ($33.1 Million) Series B ...

6 days from now

BRIGHTON, England, January 30, 2024--Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to …

yahoo.com

$33
OFF

Enterprise Therapeutics Closes £26 Million ($33.1 Million) Series B ...

6 days from now

Jan 30, 2024 · Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the liv Enterprise Therapeutics …

businesswire.com

£26
OFF

Enterprise Therapeutics Closes £26M Series B Follow-on Financing

6 days from now

Jan 30, 2024 · Enterprise Therapeutics, a Brighton, UK-based biopharmaceutical company dedicated to the discovery and development of novel therapies for respiratory disease, raised …

finsmes.com

$35000000
OFF

Series B - Cognito Therapeutics - 2024-01-29 - Crunchbase

6 days from now

Jan 29, 2024 · Cognito Therapeutics raised $35000000 on 2024-01-29 in Series B. FoundersX Ventures FoundersX Ventures, a cross-stage venture capital firm based in Menlo Park with …

crunchbase.com

$100
OFF

These Are The Industries Where Series B Funding Is Growing Fastest

6 days from now

Nov 29, 2021 · For financial services subsectors, a total of 14 U.S. companies closed Series B rounds of $100 million or more this year. Top Series B recipients included Recharge ($227 …

crunchbase.com

$100000000
OFF

Series B - BlossomHill Therapeutics - 2024-01-02 - Crunchbase

6 days from now

Jan 2, 2024 · BlossomHill Therapeutics raised $100000000 on 2024-01-02 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. ... Organization Name . BlossomHill …

crunchbase.com

$21775022
OFF

Series B - Kate Therapeutics - 2024-08-07 - Crunchbase

6 days from now

Aug 7, 2024 · Kate Therapeutics raised $21775022 on 2024-08-07 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension ... Summary. Overview. Edit Overview …

crunchbase.com

$49162194
OFF

Series B - Grey Wolf Therapeutics - 2023-01-26 - Crunchbase

6 days from now

Jan 26, 2023 · Grey Wolf Therapeutics raised $49162194 on 2023-01-26 in Series B. Pfizer Venture Investments Pfizer Venture Investments is a corporate venture capital firm that invests …

crunchbase.com

$157000000
OFF

Series B - Engrail Therapeutics - 2024-03-19 - Crunchbase

6 days from now

Mar 19, 2024 · Engrail Therapeutics raised $157000000 on 2024-03-19 in Series B. Norwest Venture Partners Norwest Venture Partners is a venture capital and growth equity investment …

crunchbase.com

FAQs about Series B - Enterprise Therapeutics - 2024-01-29 - Crunchbase Coupon?

What does enterprise Therapeutics do?

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from respiratory disease, today announced that it has closed a £26 million ($33.1 million USD) Series B follow-on financing round, led by Panakes Partners. ...

What are the biggest Series B investments in 2024?

Notably, several of the biggest Series B investments this year went to companies that closed their prior round not too long ago. The most high profile example is Elon Musk ’s xAI. The generative AI startup closed the largest Series B of 2024 — a $6 billion financing — six months after raising its previous round. ...

How many investors does enterprise therapeutics have?

Enterprise Therapeutics has 8 investors including Cystic Fibrosis Foundation and IP Group. How much funding has Enterprise Therapeutics raised to date? Enterprise Therapeutics has raised . When was the last funding round for Enterprise Therapeutics? ...

Are investors backing fewer Series B deals in 2023?

So far in 2023, Crunchbase data shows investors are backing fewer big rounds. There were just six Series B deals of $100 million or more to date this year, an average of fewer than one per week. In 2022, by comparison, there were 90 such rounds, or almost two per week. Still, we are seeing some mega-sized Series B deals this year. ...

Is Series B funding still a good investment?

When technology and biotech valuations began to tumble last year, U.S. Series B funding held up at first, offering one of the brighter areas in a more bearish investment environment. That’s no longer the case. In recent months, Series B funding to U.S. startups has fallen sharply. ...

Who owns Enterprise Therapeutics?

Dr John Ford, CEO, Enterprise Therapeutics Dr Rob Woodman, Partner, Panakes, commented: “Knowing the quality and track record of the Enterprise team, I am delighted to now be part of the next stage of its development. ...